Debt to EBITDA ratio Analysis of Vanda Pharmaceuticals Inc - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointDebt to EBITDA of VNDA
Dec-230.168Excellent Debt to EBITDA | Dec-220.244Excellent Debt to EBITDA | Growth-31.11% |
Debt to EBITDA Analysis of Vanda Pharmaceuticals Inc
| Debt to EBITDA Ratio 0.168 of Vanda Pharmaceuticals Inc shows that the company is financially strong and has enough profit to pay off its debt. |
| Debt to EBITDA Ratio of VNDA drastically fell by -31.11 % this year. |
| Debt to EBITDA Ratio with value of 0.244 was highest in Year Dec-22 in last Five Years. |
| Debt to EBITDA Ratio with value of 0.051 was lowest in Year Dec-21 in last Five Years. |
| Latest Debt to EBITDA Ratio with value of 0.168 is Greater than Average Debt to EBITDA of 0.119 in last five years. |
Other Debt to EBITDA Related Info of VNDA that may interest you.
Vanda Pharmaceuticals Inc Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| VNDA | 5.11 | 5.01 | 2.00 % | Biotechnology |
Defination of Debt to EBITDA
The Debt to EBITDA Ratio is a solvency metric that measures the company's ability to meet its debt obligations by earnings before covering its interest, taxes, depreciation, and amortization. more ..
Debt to EBITDA Related Ratios
| CashFlowFromOperationToDebt | DebtToCapital | EVToEBITDA |
Tsr Stability Index
| Excellent Stability | |
FY - Historical Debt to EBITDA of Vanda Pharmaceuticals Inc
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
|---|---|---|---|---|---|---|---|
| Debt to EBITDA | 0.168 | 0.244 | 0.051 | 0.064 | 0.067 | 0 | -2.17 |
| Change | -31.11 % | 376.63 % | -20.21 % | -4.74 % | 0 % | 47.61 % |
FY Chart of Debt to EBITDA of Vanda Pharmaceuticals Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)